(Reuters) -The Centers for Medicare & Medicaid Services said on Friday that it did not move forward with a proposal put forth by the Biden administration on Medicare coverage of weight-loss drugs such as Novo Nordisk’s Wegovy.
(Reporting by Puyaan Singh in Bengaluru; Editing by Shinjini Ganguli)
